Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells.
about
Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Synergistic anticancer effects ...... ‑positive breast cancer cells.
@en
Synergistic anticancer effects ...... ‑positive breast cancer cells.
@nl
type
label
Synergistic anticancer effects ...... ‑positive breast cancer cells.
@en
Synergistic anticancer effects ...... ‑positive breast cancer cells.
@nl
prefLabel
Synergistic anticancer effects ...... ‑positive breast cancer cells.
@en
Synergistic anticancer effects ...... ‑positive breast cancer cells.
@nl
P2093
P2860
P356
P1476
Synergistic anticancer effects ...... ‑positive breast cancer cells.
@en
P2093
Hongki Gwak
Se Young Kim
Seung Taek Lim
Ye Won Jeon
Young Jin Suh
P2860
P304
P356
10.3892/MMR.2018.8580
P577
2018-02-08T00:00:00Z